Genomic screening has detected mutations in the tumor protein p53 (TP53),[6–9] PI3K,[6] and mitogen-activated kinase-like protein (MAPK)[10] pathways in angiosarcoma. The gene discussed is TP53; the disease is angiosarcoma.